1. Home
  2. CSBR vs DLNG Comparison

CSBR vs DLNG Comparison

Compare CSBR & DLNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSBR
  • DLNG
  • Stock Information
  • Founded
  • CSBR 1985
  • DLNG 2013
  • Country
  • CSBR United States
  • DLNG Greece
  • Employees
  • CSBR N/A
  • DLNG N/A
  • Industry
  • CSBR Biotechnology: Biological Products (No Diagnostic Substances)
  • DLNG Marine Transportation
  • Sector
  • CSBR Health Care
  • DLNG Consumer Discretionary
  • Exchange
  • CSBR Nasdaq
  • DLNG Nasdaq
  • Market Cap
  • CSBR 113.0M
  • DLNG 143.7M
  • IPO Year
  • CSBR 1986
  • DLNG 2013
  • Fundamental
  • Price
  • CSBR $7.90
  • DLNG $3.45
  • Analyst Decision
  • CSBR Strong Buy
  • DLNG
  • Analyst Count
  • CSBR 1
  • DLNG 0
  • Target Price
  • CSBR $12.00
  • DLNG N/A
  • AVG Volume (30 Days)
  • CSBR 36.4K
  • DLNG 59.7K
  • Earning Date
  • CSBR 03-11-2025
  • DLNG 03-06-2025
  • Dividend Yield
  • CSBR N/A
  • DLNG 2.85%
  • EPS Growth
  • CSBR N/A
  • DLNG 59.08
  • EPS
  • CSBR 0.46
  • DLNG 1.05
  • Revenue
  • CSBR $58,591,000.00
  • DLNG $156,403,000.00
  • Revenue This Year
  • CSBR $15.11
  • DLNG N/A
  • Revenue Next Year
  • CSBR $7.80
  • DLNG $0.37
  • P/E Ratio
  • CSBR $17.27
  • DLNG $3.28
  • Revenue Growth
  • CSBR 19.03
  • DLNG N/A
  • 52 Week Low
  • CSBR $3.60
  • DLNG $3.18
  • 52 Week High
  • CSBR $11.99
  • DLNG $5.65
  • Technical
  • Relative Strength Index (RSI)
  • CSBR 43.84
  • DLNG 41.15
  • Support Level
  • CSBR $7.61
  • DLNG $3.23
  • Resistance Level
  • CSBR $8.86
  • DLNG $3.58
  • Average True Range (ATR)
  • CSBR 0.69
  • DLNG 0.22
  • MACD
  • CSBR 0.04
  • DLNG 0.02
  • Stochastic Oscillator
  • CSBR 44.28
  • DLNG 46.55

About CSBR Champions Oncology Inc.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

About DLNG Dynagas LNG Partners LP Common Units

Dynagas LNG Partners LP is a limited partnership company focused on owning and operating high specification and versatile LNG carriers that are employed on multi-year contracts with international energy companies, providing the benefits of stable cash flows and high utilization rates. The company defines charters of two years or more as multi-year charters. Its current LNG Carrier fleet is optimized for trading flexibility. In addition to conventional trade, part of LNG Carrier fleet is assigned with Ice Class 1A FS notation and are winterized which enables trade in subzero and ice bound conditions.

Share on Social Networks: